RU2006102664A - Новый способ получения имипенема - Google Patents

Новый способ получения имипенема Download PDF

Info

Publication number
RU2006102664A
RU2006102664A RU2006102664/04A RU2006102664A RU2006102664A RU 2006102664 A RU2006102664 A RU 2006102664A RU 2006102664/04 A RU2006102664/04 A RU 2006102664/04A RU 2006102664 A RU2006102664 A RU 2006102664A RU 2006102664 A RU2006102664 A RU 2006102664A
Authority
RU
Russia
Prior art keywords
compound
formula
nitrobenzyl
ketone
group
Prior art date
Application number
RU2006102664/04A
Other languages
English (en)
Other versions
RU2314308C2 (ru
Inventor
Хиун Сеоп БАЕ (KR)
Хиун Сеоп БАЕ
Тае Сеоп ХВАНГ (KR)
Тае Сеоп ХВАНГ
Чан Йонг АХН (KR)
Чан Йонг АХН
Чанг Хоон ОХ (KR)
Чанг Хоон ОХ
Моо Сунг КИМ (KR)
Моо Сунг КИМ
Original Assignee
Чоонгвае Фарм.Ко. (Kr)
Чоонгвае Фарм.Ко.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чоонгвае Фарм.Ко. (Kr), Чоонгвае Фарм.Ко. filed Critical Чоонгвае Фарм.Ко. (Kr)
Publication of RU2006102664A publication Critical patent/RU2006102664A/ru
Application granted granted Critical
Publication of RU2314308C2 publication Critical patent/RU2314308C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Claims (9)

1. Соединение формулы II
Figure 00000001
где R1 представляет п-нитробензильную или п-метоксибензильную группу; и R2 и R3 могут быть одинаковыми или разными, и каждый независимо представляет С1-6 алкильную или арильную группу,
или его производное.
2. Способ получения соединения формулы II
Figure 00000001
где R1 представляет п-нитробензильную или п-метоксибензильную группу; и R2 и R3 могут быть одинаковыми или разными, и каждый независимо представляет С1-6 алкильную или арильную группу, путем сочетания соединения формулы IV
Figure 00000002
где R1 представляет п-нитробензильную или п-метоксибензильную группу, или его производного с гидрохлоридом 2-аминоэтантиола в присутствии основания с последующей реакцией с кетоном.
3. Способ по п.2, в котором кетон выбран из группы, состоящей из ацетона, метилэтилкетона, дифенилкетона и их смесей.
4. Способ по п.2 или 3, в котором соединение формулы IV или его производное получают путем конденсации соединения формулы III
Figure 00000003
где R1 представляет п-нитробензильную или п-метоксибензильную группу, с дифенилхлорфосфатом в присутствии основания.
5. Способ по п.4, в котором растворитель для реакции является смешанным растворителем из ацетонитрила и тетрагидрофурана.
6. Способ по п.4, в котором температура реакции находится в интервале от 0 до -10С.
7. Способ получения соединения формулы I
Figure 00000004
путем взаимодействия соединения формулы II
Figure 00000005
где R1 представляет п-нитробензильную или п-метоксибензильную группу; и R2 и R3 могут быть одинаковыми или разными, и каждый независимо представляет С1-6 алкильную или арильную группу, с изопропилформимидатом или бензилформимидатом в присутствии основания с получением соединения формулы V
Figure 00000006
где R1 представляет п-нитробензильную или п-метоксибензильную группу, гидрирования соединения формулы V в присутствии катализатора-металла, выделения гидрированного соединения и кристаллизации выделенного соединения в присутствии спирта или кетона.
8. Способ по п.7, в котором гидрирование проводят в присутствии палладиевого катализатора, содержащего большое количество воды, при давлении водорода 4-6 кг/см2.
9. Способ по п.7, в котором растворитель для реакции является смешанным растворителем из воды и тетрагидрофурана.
RU2006102664/04A 2003-12-09 2004-12-09 Новый способ получения имипенема RU2314308C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20030088857 2003-12-09
KR10-2003-0088857 2003-12-09

Publications (2)

Publication Number Publication Date
RU2006102664A true RU2006102664A (ru) 2006-08-10
RU2314308C2 RU2314308C2 (ru) 2008-01-10

Family

ID=36642326

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006102664/04A RU2314308C2 (ru) 2003-12-09 2004-12-09 Новый способ получения имипенема

Country Status (14)

Country Link
US (1) US7507814B2 (ru)
EP (1) EP1692135A4 (ru)
JP (1) JP4500814B2 (ru)
KR (1) KR100667373B1 (ru)
CN (1) CN100383142C (ru)
AU (1) AU2004296261B2 (ru)
BR (1) BRPI0413057B8 (ru)
CA (1) CA2531578C (ru)
MX (1) MXPA06001115A (ru)
NO (1) NO20062602L (ru)
NZ (1) NZ547641A (ru)
RU (1) RU2314308C2 (ru)
WO (1) WO2005056553A1 (ru)
ZA (1) ZA200604446B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395587B1 (en) * 2001-05-18 2009-07-29 Ranbaxy Laboratories Limited Process for the preparation of imipenem
KR100667373B1 (ko) * 2003-12-09 2007-01-10 주식회사 중외제약 이미페넴의 신규 제조방법
CN102690266B (zh) * 2011-09-02 2014-06-18 深圳市海滨制药有限公司 一种制备厄他培南钠的方法
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
GB1570988A (en) * 1975-11-21 1980-07-09 Merck & Co Inc Antibiotics of the thienamycin class
US4172144A (en) * 1976-10-18 1979-10-23 Merck & Co., Inc. Schiff's base derivatives of thienamycin
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4845261A (en) 1987-05-11 1989-07-04 Merck & Co., Inc. Process for bis(substituted phenyl) phosphorohalidates
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
IN191798B (ru) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
ITMI20010077A1 (it) * 2001-01-17 2002-07-18 Acs Dobfar Spa Procedimento per la produzione dell'imipenem
EP1395587B1 (en) * 2001-05-18 2009-07-29 Ranbaxy Laboratories Limited Process for the preparation of imipenem
KR100667373B1 (ko) * 2003-12-09 2007-01-10 주식회사 중외제약 이미페넴의 신규 제조방법

Also Published As

Publication number Publication date
EP1692135A1 (en) 2006-08-23
BRPI0413057B1 (pt) 2018-02-06
AU2004296261A1 (en) 2005-06-23
KR20050056161A (ko) 2005-06-14
ZA200604446B (en) 2007-10-31
MXPA06001115A (es) 2006-04-11
JP4500814B2 (ja) 2010-07-14
US20060167243A1 (en) 2006-07-27
US7507814B2 (en) 2009-03-24
WO2005056553A1 (en) 2005-06-23
BRPI0413057A (pt) 2006-10-17
AU2004296261B2 (en) 2007-08-23
RU2314308C2 (ru) 2008-01-10
CA2531578C (en) 2008-10-07
EP1692135A4 (en) 2009-02-25
BRPI0413057B8 (pt) 2021-05-25
KR100667373B1 (ko) 2007-01-10
CN100383142C (zh) 2008-04-23
CN1829716A (zh) 2006-09-06
NZ547641A (en) 2009-02-28
NO20062602L (no) 2006-08-31
JP2007501838A (ja) 2007-02-01
CA2531578A1 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
RU2585760C2 (ru) Способ получения хиральных триазолонов
CA2861150C (en) Morphinan derivative
CA2882386C (en) Substituted pyrido[1,2-a]pyrazines and their use in the treatment of neurodegenerative and/or neurological disorders
EP0558156A2 (en) Intermediates for 3-aminopiperidine derivates
Bhat et al. Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids
Damavandi New approach to the multicomponent one-pot synthesis of 2-aryl-1 H-phenanthro [9, 10-d] imidazoles
FI87774C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva aralkylimidazolderivat
AU2013212209A1 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
HU200755B (en) Process for producing optically active alcohol derivatives by using asymmetrically modified compounds of boron hydride type
RU2006102664A (ru) Новый способ получения имипенема
Jones et al. Synthesis of 5-substituted 4-O-methyl tetramates
US20170355724A1 (en) Anthelminthic macrolide synthesis
Hunt et al. Chiral oxime ethers in asymmetric synthesis. Part 5. 1 Asymmetric synthesis of 2-substituted 5-to 8-membered nitrogen heterocycles by oxime addition–ring-closing metathesis
Mollet et al. Stereoselective synthesis of bicyclic tetrahydrofuran-fused β-lactams and their conversion into methyl cis-3-aminotetrahydrofuran-2-carboxylates
Maison et al. Synthesis of novel pipecolic acid derivatives: a multicomponent approach from 3, 4, 5, 6-tetrahydropyridines
Zhang et al. Synthesis of 2-vinyl-2 H-benzotriazoles via NIS-promoted regio/stereoselective addition of 1H-benzotriazole to alkynes
EP1731509B1 (en) Process for producing nitrogenous 5-membered cyclic compound
EP3507274B1 (de) Verfahren zur herstellung chiraler aminonitrile
Liebeschuetz et al. Rationally designed guanidine and amidine fungicides
Kotlyar et al. Prospective biologically active compounds based on 5-formylthiazole
Schlüter et al. Consecutive multicomponent reactions: synthesis of 3-Acyl-4-alkynyl-substituted 1, 3-thiazolidines
US8183365B2 (en) Synthetic method for ceratamine A and B and analogs thereof
Naumova et al. Three-step assembly of 4-aminotetrahydropyran-2-ones from isoxazoline-2-oxides
Sagirova et al. Palladium-catalyzed diastereoselective hydrogenation of N-substituted 3-methyleneisoindolin-1-ones
EP0128120A2 (de) Trisubstituierte Oxazolidinone